Cargando…
Adopting an heterologous prime-boost strategy in COVID-19 vaccination: the need for locally generated evidence in Africa
The reduction in the severity and prevalence of COVID-19 has been largely due to the rapid development and deployment of COVID-19 vaccines. Consequently, WHO, in partnership with the Coalition for Epidemic Preparedness Innovation, GAVI, the Vaccine Alliance, set up the COVID-19 Vaccines Global Acces...
Autores principales: | Oboh, Mary Aigbiremo, Omoleke, Semeeh, Salami, Kolawole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The African Field Epidemiology Network
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046858/ https://www.ncbi.nlm.nih.gov/pubmed/35519174 http://dx.doi.org/10.11604/pamj.2022.41.148.31620 |
Ejemplares similares
-
Beyond SARS-CoV-2: Lessons That African Governments Can Apply in Preparation for Possible Future Epidemics
por: Oboh, Mary Aigbiremo, et al.
Publicado: (2020) -
Translation of genomic epidemiology of infectious pathogens: Enhancing African genomics hubs for outbreaks
por: Oboh, Mary Aigbiremo, et al.
Publicado: (2020) -
Heterologous prime-boost vaccination against COVID-19: is it safe and reliable?
por: Choudhary, Om Prakash, et al.
Publicado: (2021) -
Health and Demographic Surveillance System: A Potential Tool for Solving Challenges Associated with Epidemic Surveillance and Social Protection Scheme for COVID-19 Pandemic Response in Nigeria
por: Alabi, Olatunji, et al.
Publicado: (2021) -
Chronic non-communicable disease as a new epidemic in Africa: focus on The Gambia
por: Omoleke, Semeeh A
Publicado: (2013)